Impax Laboratories (IPXL) Reports In-Line Q4 EPS
Tweet
Share
E-mailGet Alerts IPXL Hot Sheet
Price: $18.30 --0%
Financial Fact:
Cost of revenues: 136.87M
Today's EPS Names:
SYRS, EGRX, AIFC, More
Financial Fact:
Cost of revenues: 136.87M
Today's EPS Names:
SYRS, EGRX, AIFC, More
Join SI Premium – FREE
Impax Laboratories (NASDAQ: IPXL) reported Q4 EPS of $0.16, in-line with the analyst estimate of $0.16. Revenue for the quarter came in at $198.4 million versus the consensus estimate of $219.25 million.
For earnings history and earnings-related data on Impax Laboratories (IPXL) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- VNET Group (VNET) Misses Q2 EPS by 164c
- Yalla Group Limited (YALA) Reports Q2 EPS of $0.24
- iQIYI (IQ) Misses Q2 EPS by 21c
Create E-mail Alert Related Categories
Earnings, GuidanceRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
